Foley, P.
4908  results:
Search for persons X
?
 
?
3

Immunogenicity and pharmacokinetics of guselkumab among pat..:

Armstrong, A. ; Eyerich, K. ; Conrad, C....
Journal of the European Academy of Dermatology and Venereology.  37 (2023)  12 - p. , 2023
 
?
5

Bimekizumab versus secukinumab continuous maintenance of re..:

Warren, RB ; Conrad, C ; Foley, P...
SKIN The Journal of Cutaneous Medicine.  6 (2022)  6 - p. s70 , 2022
 
?
6

Super‐response to guselkumab treatment in patients with mod..:

Reich, K. ; Gordon, K.B. ; Strober, B....
Journal of the European Academy of Dermatology and Venereology.  36 (2022)  12 - p. 2393-2400 , 2022
 
?
8

PO-1064 A Registry for Analysis of Data to Advance Personal..:

Jameson, M. ; Batumalai, V. ; Woods, A....
Radiotherapy and Oncology.  170 (2022)  - p. S899-S900 , 2022
 
?
9

Innovative Widefield Volumetric Arc Radiation Therapy (VMAT..:

Potter, A.E. ; Baker, C. ; Shumack, S....
International Journal of Radiation Oncology*Biology*Physics.  114 (2022)  3 - p. S83 , 2022
 
?
 
?
11

Five‐year maintenance of clinical response and health‐relat..:

Reich, K. ; Gordon, K. B. ; Strober, B. E....
British Journal of Dermatology.  185 (2021)  6 - p. 1146-1159 , 2021
 
?
12

Ixekizumab provides persistent improvements in health‐relat..:

Ryan, C. ; Guenther, L. ; Foley, P....
Journal of the European Academy of Dermatology and Venereology.  36 (2021)  4 - p. , 2021
 
?
13

Bimekizumab Versus Ustekinumab in Plaque Psoriasis: Lasting..:

Gordon, K ; Foley, P ; Rich, P...
SKIN The Journal of Cutaneous Medicine.  5 (2021)  1 - p. s17 , 2021
 
?
14

Five‐year efficacy and safety of tildrakizumab in patients ..:

Thaci, D. ; Piaserico, S. ; Warren, R.B....
British Journal of Dermatology.  185 (2021)  2 - p. 323-334 , 2021
 
?
15

BMS-986165, inhibiteur oral sélectif de la tyrosine kinase ..:

Gordon, K. ; Papp, K. ; Gooderham, M....
Annales de Dermatologie et de Vénéréologie.  147 (2020)  12 - p. A356-A357 , 2020
 
1-15